PO.IM02.03 · 免疫学

宿主-微生物-表观遗传串扰:剖析微生物组、免疫失调和DNA甲基化在鳞状细胞癌中的作用

Host-microbe-epigenetic crosstalk: Dissecting the role of microbiome, immune dysregulation, and DNA methylation in squamous cell carcinoma

编号 2866 展板 6 时间 4/20 02:00–05:00 区域 Section 9 主讲 Armando Licata, BS;MS
分会场 Microbiome, Inflammation, and Response to Immunotherapy in Cancer
该海报暂无可下载的资料 AACR 官方页面

作者与单位 Authors & Affiliations

Armando G. Licata1, Cristina Gurizzan2, Deborah Lenoci1, Marta Lucchetta1, Carlo Resteghini3, Luigi Lorini2, Rosalba Miceli4, Paolo Bossi3, Loris De Cecco1

1Research department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy,2Department of Biomedical Sciences, IRCCS Humanitas Research Hospital, Milan, Italy,3Department of Biomedical Sciences, Humanitas University IRCCS Humanitas Research Hospital, Milan, Italy,4Unit of Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

摘要 Abstract

中文摘要
口腔和头颈部的鳞状细胞癌共享分子、微生物和免疫特征。菌群失调和瘤内微生物群越来越多地被认为与上皮转化有关,具核梭杆菌(Fusobacterium nucleatum)等菌属在各鳞状部位与炎症、缺氧、免疫逃逸和转移相关。明确宿主-微生物-免疫相互作用如何从口腔癌前病变演变为侵袭性肿瘤,可能揭示用于预防、风险分层和干预的早期生物标志物和可修饰的微生物靶点。我们采用多组学方法分析了66例口腔潜在恶性疾病(OPMD)和74例头颈部鳞状细胞癌(HNSCC)的样本。通过RNA-seq、鸟枪法宏基因组学和多重细胞因子检测对队列进行分析。使用Nanopore测序对20例HNC样本进行表观遗传学分析,以评估全基因组DNA甲基化。在OPMD中,高风险缺氧亚型显示恶性转化发生率升高(p < 0.0001)、微生物多样性降低,以及具核梭杆菌和沃氏纤毛菌(Leptotrichia wadei)丰度显著升高(Log₂FC > 1,FDR < 0.05)。F. nucleatum活性与角质形成细胞和周细胞强相关(R>0.7)。虽然HNSCC的α多样性保持稳定,但群落结构发生了变化(PERMANOVA p=0.001),其特征为乳杆菌属(Lactobacillus spp.)富集,驱动棕榈酸代谢,而OPMD则倾向于淀粉降解和硝酸盐还原。免疫分析揭示头颈部肿瘤内存在深度失调。虽然OPMD以高水平的促炎介质(TNF-alpha、IL-6)为特征,但这些细胞因子在HNSCC中显著下调。这提示从OPMD的急性炎症反应向已成型癌症的慢性免疫抑制状态的功能性转变。最后,我们的表观遗传学分析将口腔菌群失调与宿主代谢联系起来,揭示了超重HNC患者中的显著差异甲基化。我们的分析揭示了影响关键致癌和免疫调节基因的显著低甲基化,包括NOTCH1、STAT3和抗原呈递基因HLA-DRB1。我们的发现证明了头/颈部癌症进展中存在保守的微生物轨迹,其特征是Fusobacterium的富集以及从促炎向免疫逃逸型肿瘤微环境的功能性转换。这些结果指向鳞状癌症中共有的微生物病因,而正在进行的表观遗传学分析将为这些宿主-微生物相互作用如何驱动恶性转化提供更深入的机制见解。
查看英文原文 English abstract
Squamous carcinomas of the oral cavity and head and neck share molecular, microbial, and immune features. Dysbiosis and intratumoral microbiota are increasingly implicated in epithelial transformation, with taxa such as Fusobacterium nucleatum linked to inflammation, hypoxia, immune evasion, and metastasis across squamous sites. Defining how host-microbe-immune interactions evolve from oral premalignant lesions to invasive tumors could reveal early biomarkers and modifiable microbial targets for prevention, risk stratification, and intervention. We analyzed samples from 66 oral potentially malignant diseases (OPMD) and 74 head and neck squamous cell carcinoma (HNSCC) using a multi-omics approach. Cohorts were profiled via RNA-seq, shotgun metagenomics, and multiplex cytokine assays. Epigenetic profiling of 20 HNC samples was performed using Nanopore sequencing to assess genome-wide DNA methylation. In OPMDs, a high-risk hypoxic subtype showed an elevated incidence of malignant transformation (p < 0.0001), reduced microbial diversity, and significantly elevated abundance of Fusobacterium nucleatum and Leptotrichia wadei (Log₂FC > 1, FDR < 0.05). F. nucleatum activity correlated strongly (R>0.7) with keratinocytes and pericytes. While HNSCC alpha diversity remained stable, community structure shifted (PERMANOVA p=0.001), marked by an enrichment of Lactobacillus spp. driving palmitate metabolism, whereas OPMD favored starch degradation and nitrate reduction. Immune profiling revealed a profound dysregulation within head and neck tumors. While OPMD was characterized by high levels of pro-inflammatory mediators (TNF-alpha, IL-6), these cytokines were markedly downregulated in HNSCC. This suggests a functional shift from an acute inflammatory response in OPMDs toward a chronic, immune-suppressive state in established carcinoma. Finally, our epigenetic analysis linked oral dysbiosis with host metabolism, revealing significant differential methylation in overweight HNC patients. Our analysis revealed significant hypomethylation affecting key oncogenic and immunomodulatory genes, including NOTCH1, STAT3, and the antigen-presenting gene HLA-DRB1. Our findings demonstrate a conserved microbial trajectory in the progression of head/neck carcinomas, characterized by the enrichment of Fusobacterium and a functional switch from a pro-inflammatory to an immune-evasive tumor microenvironment. These results point to a shared microbial etiology in squamous cancers, and the ongoing epigenetic analysis will provide deeper mechanistic insights into how these host-microbe interactions drive malignant transformation.
利益披露 Disclosure
A. G. Licata, None.. C. Gurizzan, None.. D. Lenoci, None.. M. Lucchetta, None.. C. Resteghini, None.. L. Lorini, None.. R. Miceli, None. P. Bossi, Merck Other, Participation to advisory board or conference honoraria. Sanofi-Regeneron Other, Participation to advisory board or conference honoraria. Merck Sharp & Dohme Other, Participation to advisory board or conference honoraria. Daiichi-Sankyo Other, Participation to advisory board or conference honoraria. Glaxo Smith Kline Other, Participation to advisory board or conference honoraria. Merus Other, Participation to advisory board or conference honoraria. Sun Pharma Other, Participation to advisory board or conference honoraria. Pfizer Other, Participation to advisory board or conference honoraria. Genmab Other, Participation to advisory board or conference honoraria. Angelini Other, Participation to advisory board or conference honoraria. Nestlè Other, Participation to advisory board or conference honoraria. Nutricia Other, Participation to advisory board or conference honoraria. L. De Cecco, None.

← 返回 AACR 2026 检索